Monopar Therapeutics Insider Trades

MNPR

Track insider trading activity from Monopar Therapeutics executives and directors. See which insiders are buying and selling MNPR stock.

Trades Last 12 Months

MNPR Price

All Insider Trades for Monopar Therapeutics

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Robinson Chandler Chief Executive Officer
Holding Value $7.32M 104,127 shares
Last Trade
Oct 20, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$44.3k 597 shares
$74.23
$70.32
Holding Value $591k 8,400 shares
Last Trade
Oct 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$655k 8,400 shares
$77.97
$70.32
Vu Quan Anh Chief Financial Officer
Holding Value $561k 7,984 shares
Last Trade
Sep 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$48.9k 614 shares
$79.67
$70.32
Cittadine Andrew Chief Operating Officer
Holding Value $2.47M 35,115 shares
Last Trade
Sep 30, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$349k 4,384 shares
$79.67
$70.32
Tsuchimoto Kim R Director
Holding Value $254k 3,605 shares
Last Trade
Aug 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$456k 4,090 shares
$111.39
$70.32
Rioux Patrice other, Acting Chief Medical Officer
Holding Value $356k 5,066 shares
Last Trade
Aug 26, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$314k 2,760 shares
$113.72
$70.32
Anderson Raymond Director
Holding Value $599k 8,515 shares
Last Trade
Aug 25, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$704k 6,284 shares
$111.96
$70.32
Sweeny Nicole Director
Holding Value $90.3k 1,284 shares
Last Trade
Jun 26, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$113k 1,284 shares
$87.68
$70.32
Rioux Patrice other, Acting Chief Medical Officer
Holding Value $141k 2,000 shares
Last Trade
Jan 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$131k 2,000 shares
$65.30
$70.32
Holding Value $649k 9,223 shares
Last Trade
Dec 18, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$312k 4,660 shares
$67.06
$70.32
Hendricks Diane 10% owner
Holding Value $39.9M 567,580 shares
Last Trade
Dec 16, 2025 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$3.11M 43,499 shares
$71.47
$70.32
Talukdar Lavina Director
Holding Value $206k 2,924 shares
Last Trade
Dec 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 2,924 shares
$75.94
$70.32
Holding Value $206k 2,924 shares
Last Trade
Dec 02, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 2,924 shares
$75.94
$70.32
Tactic Pharma Llc 10% owner
Holding Value $19.1M 272,026 shares
Last Trade
Sep 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$40.2M 550,229 shares
$73.04
$70.32
Tacticgem Llc 10% owner
Holding Value $0 0 shares
Last Trade
Dec 09, 2024 Sale (Other)Another type of insider transaction reported on SEC Form 4.
$31.9M 1,433,334 shares
$22.28
$70.32
Radhakrishnan Karthik Chief Financial Officer
Holding Value $109k 1,550 shares
Last Trade
Oct 28, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$25.2k 1,550 shares
$16.25
$70.32
Brown Michael J Director
Holding Value $0 0 shares
Last Trade
Dec 31, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.31k 2,533 shares
$1.70
$70.32
Mazar Andrew Paul Director, Chief Scientific Officer
Holding Value $6.24M 88,792 shares
Last Trade
Mar 31, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$20.5k 1,606 shares
$12.75
$70.32
Holding Value $6.43M 91,500 shares
Last Trade
Jul 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.56M 91,500 shares
$27.94
$70.32
Holding Value $11M 156,250 shares
Last Trade
Dec 18, 2019 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$70.32

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up